BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang JF, Zhao ZH, Zhang Y, Zhao L, Yang LM, Zhang MM, Wang BY, Wang T, Lu BC. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma. World J Gastroenterol 2016; 22(13): 3652-3662 [PMID: 27053857 DOI: 10.3748/wjg.v22.i13.3652] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Balaceanu LA. Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis. World J Clin Cases 2019; 7(12): 1367-1382 [PMID: 31363465 DOI: 10.12998/wjcc.v7.i12.1367] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
2 Fukuda H, Numata K, Hara K, Nozaki A, Kondo M, Chuma M, Nakano M, Nozawa A, Maeda S, Tanaka K. Comparison of vascularity observed using contrast-enhanced 3D ultrasonography and pathological changes in patients with hepatocellular carcinoma after sorafenib treatment. J Cancer 2018;9:2408-14. [PMID: 30026837 DOI: 10.7150/jca.24236] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
3 Ippoliti M, Lukas M, Brenner W, Schaeffter T, Makowski MR, Kolbitsch C. 3D nonrigid motion correction for quantitative assessment of hepatic lesions in DCE-MRI. Magn Reson Med 2019;82:1753-66. [PMID: 31228296 DOI: 10.1002/mrm.27867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
4 Luo J, Zhou K, Zhang B, Luo N, Bian J. Intravoxel Incoherent Motion Diffusion-Weighted Imaging for Evaluation of the Cell Density and Angiogenesis of Cirrhosis-Related Nodules in an Experimental Rat Model: Comparison and Correlation With Dynamic Contrast-Enhanced MRI. J Magn Reson Imaging 2020;51:812-23. [PMID: 31245888 DOI: 10.1002/jmri.26845] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhou X, Gao F, Duan S, Zhang L, Liu Y, Zhou J, Bai G, Tao W. Radiomic features of Pk-DCE MRI parameters based on the extensive Tofts model in application of breast cancer. Phys Eng Sci Med 2020;43:517-24. [PMID: 32524436 DOI: 10.1007/s13246-020-00852-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li J, Zhang XB, Wang JJ, Jin LJ, Shan HS, Zhang X, Ma L, Xue XD, Zhang X, Zhang ZL, Meng LL, Yuan F, Xiao YY. Comparison between high-frequency irreversible electroporation and irreversible electroporation ablation of small swine liver: follow-up of DCE-MRI and pathological observations. Chin Med J (Engl) 2021. [PMID: 34172620 DOI: 10.1097/CM9.0000000000001663] [Reference Citation Analysis]
7 Granata V, Grassi R, Fusco R, Belli A, Cutolo C, Pradella S, Grazzini G, La Porta M, Brunese MC, De Muzio F, Ottaiano A, Avallone A, Izzo F, Petrillo A. Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma. Infect Agent Cancer 2021;16:53. [PMID: 34281580 DOI: 10.1186/s13027-021-00393-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ghodasara S, Pahwa S, Dastmalchian S, Gulani V, Chen Y. Free-Breathing 3D Liver Perfusion Quantification Using a Dual-Input Two-Compartment Model. Sci Rep 2017;7:17502. [PMID: 29235486 DOI: 10.1038/s41598-017-17753-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
9 Li J, Xue F, Xu X, Wang Q, Zhang X. Dynamic contrast-enhanced MRI differentiates hepatocellular carcinoma from hepatic metastasis of rectal cancer by extracting pharmacokinetic parameters and radiomic features. Exp Ther Med 2020;20:3643-52. [PMID: 32855716 DOI: 10.3892/etm.2020.9115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Campos M, Candelária I, Papanikolaou N, Simão A, Ferreira C, Manikis GC, Caseiro-Alves F. Perfusion Magnetic Resonance as a Biomarker for Sorafenib-Treated Advanced Hepatocellular Carcinoma: A Pilot Study. GE Port J Gastroenterol 2019;26:260-7. [PMID: 31328140 DOI: 10.1159/000493351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tao WJ, Zhang HX, Zhang LM, Gao F, Huang W, Liu Y, Zhu Y, Bai GJ. Combined application of pharamcokinetic DCE-MRI and IVIM-DWI could improve detection efficiency in early diagnosis of ductal carcinoma in situ. J Appl Clin Med Phys 2019;20:142-50. [PMID: 31124276 DOI: 10.1002/acm2.12624] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Liang H, Hu C, Lu J, Zhang T, Jiang J, Ding D, Du S, Duan S. Correlation of radiomic features on dynamic contrast-enhanced magnetic resonance with microvessel density in hepatocellular carcinoma based on different models. J Int Med Res 2021;49:300060521997586. [PMID: 33682491 DOI: 10.1177/0300060521997586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]